Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-24-004221
Filing Date
2024-04-03
Accepted
2024-04-03 17:15:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 ndra_424b5.htm 424B5 117545
2 ndra_s3aimg14.jpg GRAPHIC 11710
3 ndra_s3img2.jpg GRAPHIC 56427
  Complete submission text file 0001654954-24-004221.txt   212789
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277058 | Film No.: 24820059
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)